Application 018868
- Type
- NDA
- Sponsor
- KALAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018868-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | ||
| N018868-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | Baxter Healthcare Corporation | c71371a7-75c5-45b8-b762-8d782d4c71bc | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | Sagent Pharmaceuticals | d76bd85a-8e57-477e-9607-c9435f1e26fb | 2025-06-26 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Solco Healthcare LLC | 6a0fb397-63ae-4fce-bddf-16a91b1b7a2f | 2025-06-18 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Maiva Pharma Private Limited | e5880bf4-5037-4813-b7cc-656a6832ecb5 | 2025-06-13 | Warnings | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Prefferred Pharmaceuticals Inc. | ede9846b-b4c5-4be2-9188-fd65e66cd893 | 2025-04-30 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Coupler LLC | 33ec71e2-8fbd-0703-e063-6294a90a62e1 | 2025-04-29 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Chartwell RX, LLC | 8ebd2f10-acfc-48a4-a5db-f20377bda9ce | 2025-03-26 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Hikma Pharmaceuticals USA Inc. | ddfc41a9-37d4-49c1-bbf3-969a98cd649c | 2025-03-10 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Avenacy Inc. | 7d0db0f7-bf4f-4b0b-9359-2a838626e04b | 2025-02-28 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Rising Pharma Holdings, Inc. | 6101b9b4-f3ef-438e-a857-b4ea55ffc679 | 2025-02-21 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Camber Pharmaceuticals, Inc. | f6221cce-e586-4002-bd14-6ec22eb14e2e | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Ipca Laboratories Limited | 0acd293b-ecab-4879-a8e7-cd1b76148f2a | 2025-01-20 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 809d9734-12dd-3b1f-e053-2a91aa0aadee | 2025-01-02 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 813c8e9b-61bc-27c4-e053-2a91aa0a9f45 | 2024-12-26 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | c794c95a-654e-48fe-9596-201fc122ff75 | 2024-12-09 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | 3747bbcd-783d-4baa-bb5b-b6827bf390e3 | 2024-12-09 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Devatis Inc. | c90bcb14-eb8d-4753-b339-3469c664ecd2 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 114f4f4f-536a-4658-8fd0-2dd8c029b19a | 2024-09-17 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 25c0aded-ffcd-4145-a48c-76c5fb220f61 | 2024-08-23 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 0dd28e18-2e15-45eb-9a61-a9de7bd7d64e | 2024-08-23 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.